Tumor Immunity: Exploring the Role of a Checkpoint - CME-Certified

Society for Immunotherapy of Cancer (SITC) and Medscape Oncology are excited to announce our second activity, "Tumor Immunity: Exploring the Role of a Checkpoint." The goal of this activity is to review the concept of immune checkpoints and their role in tumor growth and tumor death.

This activity is part of Clinical Advances in Immuno-Oncology, a new, robust online learning center designed to provide oncologists with FREE, CME-certified education on the topic of immunotherapy. This online learning center was developed through a strategic partnership between SITC and Medscape, and it includes a variety of CME-certified educational activities.

During this engaging program, participants will be prompted to answer questions related to the illustrated discussion, and physicians can earn a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Throughout 2014, SITC and Medscape will release additional unique CME-certified activities covering topics ranging from immunology fundamentals to tumor-specific immunotherapy education. Please stay tuned for additional activities to come!

Previously Released Activities

Concepts in Immuno-Oncology: Understanding the Key Players CME Learn about adaptive immunity and immune checkpoints. April 30, 2014